Ninacent (Capsule 150 mg)

Ninacent is indicated in- adults for the treatment of Idiopathic Pulmonary Fibrosis (IPF). adults for the treatment of chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. adults for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD). combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology after first-line chemotherapy. * রেজিস্টার্ড চিকিৎসকের পরামর্শ মোতাবেক ঔষধ সেবন করুন'

Add to cart